Effectiveness of the South African expanded program of immunization against hepatitis B in children infected with human immunodeficiency virus‐1 living in a resource‐limited setting of Kwazulu‐Natal
Prevalence of Human-Immunodeficiency-Virus/Hepatitis-B-virus (HIV/HBV) coinfection and HBV vaccination response in children are unknown in Kwazulu-Natal. This study included 183 HIV-infected and 108 HIV-uninfected children aged between 5 and 15 years screened for HBV infection and vaccination. HBV infection occurred in 2.1% and 0% of HIV-infected and uninfected children respectively. Serological response to immunization was shown in 15.8% and 61.1% of HIV-infected and uninfected children, respectively (P<0.001). Even if prevalence of HBV infection was low in these cohorts, HIV-infected children will stay at risk of infection if the vaccine schedule is not adapted. J. Med. Virol. 89:182-185, 2017. © 2016 Wiley Periodicals, Inc..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:89 |
|---|---|
| Enthalten in: |
Journal of medical virology - 89(2017), 1, Seite 182-185 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Beghin, Jean‐Christophe [VerfasserIn] |
|---|
| Links: |
|---|
| BKL: | |
|---|---|
| Themen: |
Children & youth |
| RVK: |
|---|
| doi: |
10.1002/jmv.24598 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1987073436 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1987073436 | ||
| 003 | DE-627 | ||
| 005 | 20230508064609.0 | ||
| 007 | tu | ||
| 008 | 170207s2017 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1002/jmv.24598 |2 doi | |
| 028 | 5 | 2 | |a PQ20170301 |
| 035 | |a (DE-627)OLC1987073436 | ||
| 035 | |a (DE-599)GBVOLC1987073436 | ||
| 035 | |a (PRQ)p1578-eb0438744a9e794146e4fbe56cbe3ea0357d6f1f203cc319ad462997a647fc8c3 | ||
| 035 | |a (KEY)0015763520170000089000100182effectivenessofthesouthafricanexpandedprogramofimm | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 084 | |a XA 10000 |q AVZ |2 rvk | ||
| 084 | |a 44.00 |2 bkl | ||
| 100 | 1 | |a Beghin, Jean‐Christophe |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effectiveness of the South African expanded program of immunization against hepatitis B in children infected with human immunodeficiency virus‐1 living in a resource‐limited setting of Kwazulu‐Natal |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a Prevalence of Human-Immunodeficiency-Virus/Hepatitis-B-virus (HIV/HBV) coinfection and HBV vaccination response in children are unknown in Kwazulu-Natal. This study included 183 HIV-infected and 108 HIV-uninfected children aged between 5 and 15 years screened for HBV infection and vaccination. HBV infection occurred in 2.1% and 0% of HIV-infected and uninfected children respectively. Serological response to immunization was shown in 15.8% and 61.1% of HIV-infected and uninfected children, respectively (P<0.001). Even if prevalence of HBV infection was low in these cohorts, HIV-infected children will stay at risk of infection if the vaccine schedule is not adapted. J. Med. Virol. 89:182-185, 2017. © 2016 Wiley Periodicals, Inc. | ||
| 540 | |a Nutzungsrecht: © 2016 Wiley Periodicals, Inc. | ||
| 650 | 4 | |a chronic hepatitis B | |
| 650 | 4 | |a HIV/HBV co‐infection | |
| 650 | 4 | |a resource‐limited setting | |
| 650 | 4 | |a long‐term outcome | |
| 650 | 4 | |a Hepatitis | |
| 650 | 4 | |a Vaccines | |
| 650 | 4 | |a Human immunodeficiency virus--HIV | |
| 650 | 4 | |a Immunization | |
| 650 | 4 | |a Children & youth | |
| 700 | 1 | |a Ruelle, Jean |4 oth | |
| 700 | 1 | |a Sokal, Etienne |4 oth | |
| 700 | 1 | |a Bachy, Antoine |4 oth | |
| 700 | 1 | |a Krishna, Malini |4 oth | |
| 700 | 1 | |a Hall, Leslie |4 oth | |
| 700 | 1 | |a Goubau, Patrick |4 oth | |
| 700 | 1 | |a Van der Linden, Dimitri |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of medical virology |d Hoboken, NJ : Wiley-Liss, 1977 |g 89(2017), 1, Seite 182-185 |w (DE-627)130482439 |w (DE-600)752392-0 |w (DE-576)016070275 |x 0146-6615 |7 nnns |
| 773 | 1 | 8 | |g volume:89 |g year:2017 |g number:1 |g pages:182-185 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1002/jmv.24598 |3 Volltext |
| 856 | 4 | 2 | |u http://onlinelibrary.wiley.com/doi/10.1002/jmv.24598/abstract |
| 856 | 4 | 2 | |u http://search.proquest.com/docview/1834479955 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_4012 | ||
| 936 | r | v | |a XA 10000 |
| 936 | b | k | |a 44.00 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 89 |j 2017 |e 1 |h 182-185 | ||